QXO, Inc. — fact timeline

QXO, Inc. incurred senior notes of $1,500.0 million with Holders of the Notes at 6.875% per annum maturing July 15, 2034.

“On June 17, 2026, QXO Building Products, Inc. (the “Issuer”), a wholly owned subsidiary of QXO, Inc. (“QXO”), completed the previously announced sale of $1,500.0 million of the Issuer’s 6.500% Senior Notes due 2031 (the “2031 Notes”) and $1,500.0 million of the Issuer’s 6.875% Senior Notes due 2034 (the “2034 Notes” and, together with the 2031 Notes, the “Notes”) in a private offering (the “Offering”) exempt from the registration requirements of the Securities Act of 1933, as amended.”

QXO, Inc. incurred senior notes of $1,500.0 million with Holders of the Notes at 6.500% per annum maturing July 15, 2031.

“On June 17, 2026, QXO Building Products, Inc. (the “Issuer”), a wholly owned subsidiary of QXO, Inc. (“QXO”), completed the previously announced sale of $1,500.0 million of the Issuer’s 6.500% Senior Notes due 2031 (the “2031 Notes”) and $1,500.0 million of the Issuer’s 6.875% Senior Notes due 2034 (the “2034 Notes” and, together with the 2031 Notes, the “Notes”) in a private offering (the “Offering”) exempt from the registration requirements of the Securities Act of 1933, as amended.”

QXO, Inc. entered into Indenture with Wilmington Trust, National Association valued at $1,500.0 million of 6.500% Senior Notes due 2031 and $1,500.0 million of 6.875% Senior Notes due 203 (effective 2026-06-17).

“The Notes were issued pursuant to an Indenture, dated as of June 17, 2026 (the “Indenture”), between the Issuer and Wilmington Trust, National Association, as trustee”

QXO, Inc. reported the fiscal quarter ended March 31, 2026 results: revenue $1,730.2, net income $(227.1), EPS $(0.35).

“$(0.12) for the three months ended March 31, 2026. FIRST QUARTER 2026 SUMMARY RESULTS Three Months Ended March 31, (in millions, except for per share data) 2026 2025 Net sales $ 1,730.2 $ 13.5 Net (loss) income $ (227.1) $ 8.8 Net margin (13.1) % 65.2 % Adjusted EBITDA (1) $ 1.2 $ (9.0) Adjusted EBITDA Margin (1) 0.1 % (66.7) % Adjusted Net Loss (1) $ (57.2) N/M”

QXO, Inc. shareholders approved Non-binding advisory vote to approve the executive compensation for the Company’s named executive officers as presented in the 2026 Proxy Statement. at the 2026-05-05 meeting.

“Proposal No. 3 – Stockholders approved the executive compensation for the Company’s named executive officers as presented in the 2026 Proxy Statement on a non-binding, advisory basis. The final votes were: For 685,011,490 Against 17,106,083 Abstain 648,519 Broker Non-Votes 68,471,492”

QXO, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-05-05 meeting.

“Proposal No. 2 – Stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The final votes were: For 769,798,979 Against 1,195,792 Abstain 242,813 Broker Non-Votes 0”

QXO, Inc. shareholders approved Election of seven directors to hold office until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified. at the 2026-05-05 meeting.

“Proposal No. 1 – Stockholders elected seven directors to hold office until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified. The final votes with respect to each director nominee were: For Against Abstentions Broker Non-Votes Brad Jacobs 697,420,464 5,134,231 211,397 68,471,492 Jason Aiken 701,193,574 1,360,735 211,783 68,471,492 Marlene Colucci 691,481,576 7,581,392 3,703,124 68,471,492 Mario Harik 699,490,909 3,070,421 204,762 68,471,492 Mary Kissel 700,149,277 2,209,873 406,942 68,471,492 Jared Kushner 694,743,033 6,270,023 1,753,036 68,471,492 Allison Landry 699,143,435 3,336,733 285,924 68,471,492”

QXO, Inc. entered into Agreement and Plan of Merger with TopBuild Corp. (effective 2026-04-18).

“On April 18, 2026, QXO, Inc., a Delaware corporation (“QXO”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with TopBuild Corp., a Delaware corporation (“TopBuild”), Titanium MergerCo, Inc., a Delaware corporation and wholly owned subsidiary of QXO (“Titanium Merger Sub”) and Titanium MergerCo 2, LLC, a Delaware limited liability company and wholly owned subsidiary of QXO (“Forward Merger Sub”).”

QXO, Inc. issued preferred stock.

“On April 1, 2026, QXO filed a certificate of designations (the “Certificate of Designations”) with the Secretary of State of the State of Delaware to establish the preferences, limitations and relative rights of QXO’s Series C Convertible Perpetual Preferred Stock (the “Series C Preferred Stock”).”

QXO, Inc.: Filed Certificate of Designations to establish Series C Convertible Perpetual Preferred Stock preferences and rights (effective 2026-04-01).

“On April 1, 2026, QXO filed a certificate of designations (the “Certificate of Designations”) with the Secretary of State of the State of Delaware to establish the preferences, limitations and relative rights of QXO’s Series C Convertible Perpetual Preferred Stock (the “Series C Preferred Stock”). The Certificate of Designations became effective upon filing.”

QXO, Inc. completed an acquisition involving Kodiak Building Partners Inc. for $2,000,000,000 plus 13,157,895 shares of QXO Common Stock (closed 2026-04-01).

“owned subsidiary of QXO. At the effective time of the Merger (the “Effective Time”), QXO paid to equityholders of Kodiak (“Kodiak Stockholders”) an amount in cash equal to $2,000,000,000 (subject to customary adjustments for working capital, indebtedness, cash and transaction expenses as set forth in the Merger Agreement) plus 13,157,895 shares (the”

QXO, Inc. entered into Agreement and Plan of Merger with Kodiak Building Partners Inc. valued at $2,000,000,000 plus 13,157,895 shares (effective 2026-02-10).

“On February 10, 2026, QXO, Inc., a Delaware corporation (“QXO”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), with Kodiak Building Partners Inc., a Delaware corporation (“Kodiak”), Juno Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of QXO (“Merger Sub”), and CSC Shareholder Services LLC, in its capacity as shareholder representative (the “Shareholder Representative”).”

QXO, Inc. entered into Underwriting Agreement with BofA Securities, Inc. valued at Sale of 31,645,570 shares of common stock at $23.80 per share; net proceeds approximately $750 milli (effective 2026-01-15).

“On January 15, 2026, QXO, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with BofA Securities, Inc. (the “Underwriter”), pursuant to which the Company agreed to sell 31,645,570 shares of the Company’s common stock, par value $0.00001 per share (“Common Stock”), at a public offering price of $23.80 per share (the “Offering”).”

QXO, Inc. entered into Investment Agreement with AP Quince Holdings, L.P. and other investors valued at aggregate purchase price of $3.0 billion (effective 2026-01-12).

“On January 12, 2026, QXO, Inc. (“QXO” or the “Company”) and certain new investors entered into joinders to the Investment Agreement, dated as of January 5, 2026 (the “Investment Agreement”), among AP Quince Holdings, L.P., a fund managed by affiliates of Apollo Global Management, Inc., and the other investors party thereto (collectively, the “Convertible Preferred Investors”).”

QXO, Inc. issued up to 114,500 shares of Series C Convertible Perpetual Preferred Stock of preferred stock to AP Quince Holdings, L.P. and other investors for aggregate purchase price of $1,145 million at $10,000 per share.

“Pursuant to the Investment Agreement, on the terms and subject to the conditions set forth therein, the Convertible Preferred Investors committed until July 15, 2026 (the “Initial Commitment Period”) to purchase up to 114,500 shares in the aggregate of a new series of Series C Convertible Perpetual Preferred Stock, par value $0.001 per share (the “Series C Preferred Stock”), of QXO for an aggregate purchase price of $1,145 million (at a stated value of $10,000 per share) (the “Convertible Preferred Investment”) to fund one or more Qualifying Acquisitions (as defined below), in a transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”).”

QXO, Inc. entered into Investment Agreement with AP Quince Holdings, L.P., a fund managed by affiliates of Apollo Global Management, Inc. and the other investors party thereto valued at $1,145 million (effective 2026-01-05).

“On January 5, 2026, QXO, Inc. (“QXO” or the “Company”) entered into an Investment Agreement (the “Investment Agreement”) with AP Quince Holdings, L.P., a fund managed by affiliates of Apollo Global Management, Inc. (together with its affiliates, the “Apollo Investor”) and the other investors party thereto (and, together with the Apollo Investor, the “Convertible Preferred Investors”).”

QXO, Inc. incurred term loan of $2.25 billion with Goldman Sachs Bank USA at Term SOFR or base rate plus applicable margin maturing April 30, 2032.

“The Borrower borrowed the entire $2.25 billion and used the borrowings under the Term Loan Facility”

QXO, Inc. incurred senior notes of $2.25 billion aggregate principal amount with Wilmington Trust, National Association at 6.75% maturing April 30, 2032.

“On April 29, 2025, Merger Sub (the " Issuer ") completed its previously announced offering of $2.25 billion aggregate principal amount of 6.75% Senior Secured Notes due 2032 (the " Notes ").”

QXO, Inc. completed an acquisition involving Beacon for $124.35 per share in cash (closed 2025-04-29).

“commenced on January 27, 2025 and contemplated a purchase of all of the outstanding shares of common stock, par value $0.01 per share, of Beacon (the “ Shares ”) at a price of $124.25 per share (such offer, as amended prior to the execution of the Merger Agreement, the “ January Offer ”), to increase the purchase price of the Shares to $124.35 per share (such”

QXO, Inc. engaged Deloitte & Touche LLP as its auditor.

“On March 25, 2025, the Committee approved the appointment of Deloitte & Touche LLP (“Deloitte”) as the Company’s new independent registered public accounting firm for the fiscal year ending December 31, 2025, and related interim periods, subject to Deloitte’s customary client acceptance procedures.”

QXO, Inc. dismissed Marcum LLP as its auditor.

“On March 25, 2025, the Audit Committee (the “Committee”) of the Board of Directors of QXO, Inc. (the “Company”) approved the decision to change the Company’s independent registered public accounting firm and dismissed Marcum LLP (“Marcum”) as its independent registered public accounting firm for the fiscal year ending December 31, 2025.”

Jared C. Kushner was appointed as Director at QXO, Inc..

“appointed Jared C. Kushner to the Board, effective the same day.”

Ihsan Essaid was appointed as Chief Financial Officer at QXO, Inc..

“On July 15, 2024, the Company formally appointed Mr. Essaid (age 57) the Chief Financial Officer of the Company, and Mr. Essaid began his employment as Chief Financial Officer with the Company.”

Brad Jacobs was elected as Chairman of the Board at QXO, Inc..

“Mr. Jacobs was elected as the Chairman of the Board effective upon the closing of the Equity Investment.”

Allison Landry was appointed as Director at QXO, Inc..

“the Board appointed each of the JPE designees as directors of the Company, effective immediately following the closing of the Equity Investment: Brad Jacobs, Jason Aiken, Marlene Colucci, Mario Harik, Mary Kissel and Allison Landry.”

Mary Kissel was appointed as Director at QXO, Inc..

“the Board appointed each of the JPE designees as directors of the Company, effective immediately following the closing of the Equity Investment: Brad Jacobs, Jason Aiken, Marlene Colucci, Mario Harik, Mary Kissel and Allison Landry.”

Mario Harik was appointed as Director at QXO, Inc..

“the Board appointed each of the JPE designees as directors of the Company, effective immediately following the closing of the Equity Investment: Brad Jacobs, Jason Aiken, Marlene Colucci, Mario Harik, Mary Kissel and Allison Landry.”

Marlene Colucci was appointed as Director at QXO, Inc..

“the Board appointed each of the JPE designees as directors of the Company, effective immediately following the closing of the Equity Investment: Brad Jacobs, Jason Aiken, Marlene Colucci, Mario Harik, Mary Kissel and Allison Landry.”

Jason Aiken was appointed as Director at QXO, Inc..

“the Board appointed each of the JPE designees as directors of the Company, effective immediately following the closing of the Equity Investment: Brad Jacobs, Jason Aiken, Marlene Colucci, Mario Harik, Mary Kissel and Allison Landry.”

Brad Jacobs was appointed as Director at QXO, Inc..

“the Board appointed each of the JPE designees as directors of the Company, effective immediately following the closing of the Equity Investment: Brad Jacobs, Jason Aiken, Marlene Colucci, Mario Harik, Mary Kissel and Allison Landry.”

John Schachtel resigned as Director at QXO, Inc..

“Mark Meller, Kenneth Edwards, Stanley Wunderlich and John Schachtel resigned from the Board”

Stanley Wunderlich resigned as Director at QXO, Inc..

“Mark Meller, Kenneth Edwards, Stanley Wunderlich and John Schachtel resigned from the Board”

Kenneth Edwards resigned as Director at QXO, Inc..

“Mark Meller, Kenneth Edwards, Stanley Wunderlich and John Schachtel resigned from the Board”

Mark Meller resigned as Director at QXO, Inc..

“Mark Meller, Kenneth Edwards, Stanley Wunderlich and John Schachtel resigned from the Board”

QXO, Inc. amended Amended and Restated Investment Agreement with Jacobs Private Equity II, LLC valued at $1,000,000,000 equity investment, $17,400,000 aggregate cash dividend to pre-closing stockholders (effective 2024-04-14).

“On April 14, 2024, the Company entered into an Amended and Restated Investment Agreement (the “ A&R Investment Agreement ”) with JPE (on behalf of itself and on behalf of each of the other Investors) amending and restating the Original Investment Agreement.”

QXO, Inc. shareholders approved To approve the QXO, Inc. 2024 Omnibus Incentive Plan. at the 2024-03-14 meeting.

“Proposal No. 9: To approve the QXO, Inc. 2024 Omnibus Incentive Plan. Votes For Votes Against Abstentions Broker Non-Votes 3,149,618 338,190 55,596 -”

QXO, Inc. shareholders approved To approve separately a feature of the Amended and Restated Certificate of Incorporation providing for exculpation of directors and officers to the extent permitted by the DGCL. at the 2024-03-14 meeting.

“Proposal No. 8: To approve separately a feature of the Amended and Restated Certificate of Incorporation providing for exculpation of directors and officers to the extent permitted by the Delaware General Corporation Law (the "DGCL"). Votes For Votes Against Abstentions Broker Non-Votes 3,230,447 277,983 34,974 -”

QXO, Inc. shareholders approved To approve separately a feature of the Amended and Restated Certificate of Incorporation designating the exclusive forums in which certain claims relating to the Company may be brought. at the 2024-03-14 meeting.

“Proposal No. 7: To approve separately a feature of the Amended and Restated Certificate of Incorporation designating the exclusive forums in which certain claims relating to the Company may be brought. Votes For Votes Against Abstentions Broker Non-Votes 3,459,978 42,761 40,665 -”

QXO, Inc. shareholders approved To approve separately a feature of the Amended and Restated Certificate of Incorporation specifying the circumstances under which a special meeting of stockholders may be called. at the 2024-03-14 meeting.

“Proposal No. 6: To approve separately a feature of the Amended and Restated Certificate of Incorporation specifying the circumstances under which a special meeting of stockholders may be called. Votes For Votes Against Abstentions Broker Non-Votes 3,228,961 255,227 59,216 -”

QXO, Inc. shareholders approved To approve separately a feature of the Amended and Restated Certificate of Incorporation specifying the circumstances under which stockholders are able to act by written consent in lieu of a stockholder meeting. at the 2024-03-14 meeting.

“Proposal No. 5: To approve separately a feature of the Amended and Restated Certificate of Incorporation specifying the circumstances under which stockholders are able to act by written consent in lieu of a stockholder meeting. Votes For Votes Against Abstentions Broker Non-Votes 3,240,159 247,171 56,074 -”

QXO, Inc. shareholders approved To approve separately a feature of the Amended and Restated Certificate of Incorporation effecting an increase in the number of authorized shares of common stock to 2,000,000,000 and an increase in the number of authorized shares of preferred stock to 10,000,000. at the 2024-03-14 meeting.

“Proposal No. 4: To approve separately a feature of the Amended and Restated Certificate of Incorporation effecting an increase in the number of authorized shares of common stock to 2,000,000,000 and an increase in the number of authorized shares of preferred stock to 10,000,000. Votes For Votes Against Abstentions Broker Non-Votes 3,491,436 43,914 8,054 -”

QXO, Inc. shareholders approved To approve separately a feature of the Amended and Restated Certificate of Incorporation implementing the Reverse Stock Split. at the 2024-03-14 meeting.

“Proposal No. 3: To approve separately a feature of the Amended and Restated Certificate of Incorporation implementing the Reverse Stock Split (as defined in the Investment Agreement). Votes For Votes Against Abstentions Broker Non-Votes 3,497,179 44,390 1,835 -”

QXO, Inc. shareholders approved To approve the adoption of the Fifth Amended and Restated Certificate of Incorporation. at the 2024-03-14 meeting.

“Proposal No. 2: To approve the adoption of the Fifth Amended and Restated Certificate of Incorporation (the "Amended and Restated Certificate of Incorporation"), which would become effective prior to and in connection with the closing of the Equity Investment (as defined in the Investment Agreement). Votes For Votes Against Abstentions Broker Non-Votes 3,257,387 254,535 31,482 -”

QXO, Inc. shareholders approved To approve the issuance and sale to JPE and the Other Investors of the Securities, and the other transactions contemplated by the Investment Agreement. at the 2024-03-14 meeting.

“Proposal No. 1: To approve the issuance and sale to Jacobs Private Equity II, LLC, a Delaware limited liability company ("JPE"), and the Other Investors (as defined in the Investment Agreement, dated as of December 3, 2023, by and among the Company, JPE and the Other Investors (the "Investment Agreement")) of the Securities (as defined in the Investment Agreement), and the other transactions contemplated by the Investment Agreement. Votes For Votes Against Abstentions Broker Non-Votes 3,494,060 17,890 31,454 -”

QXO, Inc. shareholders approved Ratification of Marcum LLP as the Company's independent registered public accountant to audit the Company's consolidated financial statements for 2023 at the 2023-12-19 meeting.

“Ratification of Marcum LLP, the Company's independent registered public accountant, to audit the Company's consolidated financial statements for 2023”

QXO, Inc. shareholders approved Election of Mark Meller, Kenneth Edwards, Stanley Wunderlich and John Schachtel as directors at the 2023-12-19 meeting.

“Election of Mark Meller, Kenneth Edwards, Stanley Wunderlich and John Schachtel as directors to each serve a one-year term on the Board of Directors of the Company”

QXO, Inc.: Eliminated Series A Preferred Stock by filing Certificate of Elimination, returning those shares to authorized but unissued status (effective 2023-12-01).

“On December 1, 2023, SilverSun filed a Certificate of Elimination with the Secretary of State of the State of Delaware with respect to the Company’s Series A Preferred Stock (the “ Series A Preferred Stock ”), pursuant to which the Series A Preferred Stock was eliminated and returned to the status of authorized and unissued preferred shares of the Company.”

QXO, Inc. entered into Investment Agreement with Jacobs Private Equity II, LLC valued at $1,000,000,000 Equity Investment, 1,000,000 shares of Convertible Perpetual Preferred Stock, warrant (effective 2023-12-03).

“On December 3, 2023, SilverSun Technologies, Inc., a Delaware corporation (“ SilverSun ” or the “ Company ”), entered into an Investment Agreement (the “ Investment Agreement ”), with Jacobs Private Equity II, LLC, a Delaware limited liability company (“ JPE ”), and the other investors party thereto (collectively with JPE, the “ Investors ”), providing for an aggregate investment by the Investors of $1,000,000,000 in cash in the Company (collectively, the “ Equity Investment ”).”

Mark Meller was terminated as other_named_officer at QXO, Inc..

“the Amended and Restated Employment Agreement, dated as of February 4, 2016 by and between Mark Meller and the Company (the “Meller Employment Agreement”), will be terminated and liquidated as of immediately prior to the Closing.”

QXO, Inc. entered into Asset Purchase Agreement with JCS Computer Resource Corporation valued at $1,325,000 (effective 2023-11-13).

“On November 13 , 2023 (the “Effective Date”), SWK Technologies, Inc. (“SWK”), a wholly-owned subsidiary of SilverSun Technologies, Inc., entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) with JCS Computer Resource Corporation, an Illinois corporation (“JCS”)”